Baumann, D., & Offringa, R. (2020). Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy. Cell stress, 4(10), . https://doi.org/10.15698/cst2020.10.233
Chicago Style (17th ed.) CitationBaumann, Daniel, and Rienk Offringa. "Targeting Immune-checkpoint Inhibitor Resistance Mechanisms by MEK Inhibitor and Agonist Anti-CD40 Antibody Combination Therapy." Cell Stress 4, no. 10 (2020). https://doi.org/10.15698/cst2020.10.233.
MLA (9th ed.) CitationBaumann, Daniel, and Rienk Offringa. "Targeting Immune-checkpoint Inhibitor Resistance Mechanisms by MEK Inhibitor and Agonist Anti-CD40 Antibody Combination Therapy." Cell Stress, vol. 4, no. 10, 2020, https://doi.org/10.15698/cst2020.10.233.
Warning: These citations may not always be 100% accurate.